×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Moneycontrol mutual fund summit 2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
Personal Finance
Forum
Videos
you are here:
Home
News
Active Pharmaceutical Ingredient
Active Pharmaceutical Ingredient
Ads
Aurobindo Pharma clarifies, reports of Zentiva buyout 'premature', no binding agreement yet
Divi’s Lab: Better capex guidance to meet upcoming demand
Stocks On Radar: HFCL, Waaree Energies, IREDA, Orchid Pharma in focus on 20 February
Beyond COVID opportunity, what’s in for this Vitamin D API maker?
India needs holistic ecosystem to rebuild API manufacturing facilities: PwC India
India looks to corner China's API market share; mulls sops to revive old units
Coronavirus Pandemic | COVID-19 credit neutral for pharma companies for now: Ind-Ra
Ideas for Profit | This Vitamin D API maker could benefit from the Coronavirus after-effects
API export restriction: Takeaways for Indian pharma industry
How Coronavirus affects Indian pharma value chains (Part-2)
How Coronavirus affects India's pharma value chains
Tyche Industries: Strong Q2 points to step-up in utilisation levels
Laurus Labs Q2: Change in product mix and improved margins key positives
This zero debt microcap rides on strong cash flows and low valuation
Strides Shasun to demerge API, exit biotech & probiotic biz
India's trade deficit with China rises to $53 bn in FY16
Will resolve issues raised by USFDA in a timely manner: DRL
Expecting turnover of Rs 250 cr in FY17: NutraPlus
Dishman gets licence from J&J to make TB drug raw material
Aurobindo Pharma earmarks Rs 900 crore capex for 2015-16
Revenue to grow at 5-10% in FY16-17: Shilpa Medicare
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio